載入...
Profile of Trastuzumab Deruxtecan in the Management of Patients with HER2-Positive Unresectable or Metastatic Breast Cancer: An Evidence-Based Review
Trastuzumab deruxtecan is a novel antibody–drug conjugate for the treatment of advanced solid tumors, including breast cancer, which overexpress or have amplification of the human epidermal growth factor receptor 2 (HER2). The novel structure of this exciting new agent means that it can deliver a hi...
Na minha lista:
| 發表在: | Breast Cancer (Dove Med Press) |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dove
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7920506/ https://ncbi.nlm.nih.gov/pubmed/33658846 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BCTT.S245024 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|